Buy Sylogist on 110% Upside Potential Driven by Accelerated Growth

about 2 months ago

Adam Wilk

"If growth accelerates like management thinks it will to 30% or above by 2027, Sylogist could fetch around $15 Canadian per share versus $9 per share today, offering a potential 110% upside. This forecast is based on reaching near CAD $35 million in EBITDA by 2027 with a current 10x multiple."

Sylogist is presented as an attractive turnaround story in the nonprofit and government software space. With key metrics already trending positively and price targets implying more than a doubling in share price, investors are advised to consider an accumulation trade for long-term gains.